Similarly, levels of the signaling peptide Dyn A (1-8) did not correlate with dyskinesia scores, but levels of its N-terminal truncated derivative Dyn A (2-8) in the GPi correlated significantly with dyskinesia severity (Fig. 2c and Supplementary Table 3). This evidence concerns the gene GPI and drug-induced dyskinesia.